Paul Tudor Jones II acquired 25.3 Thousand Design Therapeutics shares worth $112 Thousand. That's 0.00% of their equity portfolio (1303rd largest holding). The first Design Therapeutics trade was made in Q2 2022. Since then Paul Tudor Jones II bought shares three more times and sold shares on four occasions. The stake costed the investor $67.6 Thousand, netting the investor a gain of 65% so far.